CELL INTELLIGENCE · 肿瘤细胞治疗研究

病例报告：致敏树突状细胞免疫治疗用于多种实体瘤

Case Report: Primed dendritic cell immunotherapy for multiple solid tumors.

METTL3/SERPINE2 免疫表达在膀胱尿路上皮癌中的临床病理意义

The clinicopathological significance of METTL3/SERPINE2 immunoexpression in urothelial carcinoma of the urinary bladder.

高剂量维生素 C 提高了 BCG 免疫疗法在小鼠膀胱癌异位模型中的疗效

High-dose vitamin C improves BCG immunotherapy's efficacy in a murine ectopic model of bladder cancer.

浸润性 NK 细胞影响非肌层浸润性膀胱癌 BCG 免疫治疗的疗效

Infiltrating Natural Killer cells influence the efficacy of BCG immunotherapy in non-muscle-invasive bladder cancer.

调节性 CD25+ T 细胞在膀胱癌中的预后意义：一项免疫组化分析

Prognostic Significance of Regulatory CD25+ T Cells in Bladder Cancer: An Immunohistochemical Analysis.

调节性 T 细胞似乎预示着更差的生存结局。

膀胱癌患者肿瘤引流淋巴结中的 NK 细胞亚群及其临床意义

Natural Killer Cell Subsets in Tumor Draining Lymph Nodes of Patients with Bladder Cancer and Their Clinical Implications.

这些发现强调了膀胱癌中 NK 细胞亚群的动态特性及其在疾病进展和管理中的潜在相关性，提示针对这些特定亚群的治疗策略可能具有重要意义。

肿瘤微环境中的 Th2 评分作为非肌层浸润性膀胱癌患者对卡介苗治疗反应的预测性生物标志物：一项回顾性研究

A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Guérin in patients with non-muscle invasive bladd

考虑 B 细胞行为和采样偏倚可预测膀胱癌抗 PD-L1 治疗反应

Accounting for B-cell Behavior and Sampling Bias Predicts Anti-PD-L1 Response in Bladder Cancer.

最常见泌尿生殖系统肿瘤中新兴诊断生物标志物概览

A glance at the emerging diagnostic biomarkers in the most prevalent genitourinary cancers.